Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.92M 6.81M 34.22M 97.89M
Cost of Revenue
999.12K 4.18M 5.48M 11.57M
Gross Profit
2.92M 2.63M 28.74M 86.31M
Operating Income
-40.08M -42.71M -11.59M 46.06M
Interest Income
1.09M 1.16M 704.04K 45.63K
Pretax Income
-37.58M -38.11M -18.85M 45.64M
Net Income
-37.64M -35.33M -14.24M 36.66M
Selling & General & Admin
20.64M 21.14M 21.61M 24.95M
Research & Development
20.98M 22.96M 17.44M 14.96M
Other Expenses
1.38M 1.23M 1.28M 335.36K
Operating Expenses
43M 45.33M 40.33M 40.25M
Interest Expense
n/a n/a 14.88M n/a
Selling & Marketing Expenses
4.48M 6.86M 7.34M 13.4M
Cost & Expenses
43M 49.52M 45.81M 51.82M
Income Tax Expense
57.37K -2.78M -4.61M 8.98M
Shares Outstanding (Basic)
30.34M 29.35M 31.48M 28.87M
Shares Outstanding (Diluted)
30.34M 29.35M 31.48M 29.9M
EPS (Basic)
-1.24 -1.2 -0.45 1.27
EPS (Diluted)
-1.24 -1.2 -0.45 1.23
EBITDA
-38.7M -41.48M -10.31M 46.4M
EBIT
-40.08M -42.71M -11.59M 46.06M
Depreciation & Amortization
1.38M 1.23M 1.31M 335.36K